Background: Knowledge about Klinefelter syndrome (KS) has increased substantially since its first description almost 80 years ago. A variety of treatment options concerning the spectrum of symptoms associated with KS exists, also regarding aspects beyond testicular dysfunction. Nevertheless, the diagnostic rate is still low in relation to prevalence and no international guidelines are available for KS. Objective: To create the first European Academy of Andrology (EAA) guidelines on KS. Methods: An expert group of academicians appointed by the EAA generated a consensus guideline according to the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) system. Results: Clinical features are highly variable among patients with KS, although common characteristics are severely attenuated spermatogenesis and Leydig cell impairment, resulting in azoospermia and hypergonadotropic hypogonadism. In addition, various manifestations of neurocognitive and psychosocial phenotypes have been described as well as an increased prevalence of adverse cardiovascular, metabolic and bone-related conditions which might explain the increased morbidity/mortality in KS. Moreover, compared to the general male population, a higher prevalence of dental, coagulation and autoimmune disorders is likely to exist in patients with KS. Both genetic and epigenetic effects due to the supernumerary X chromosome as well as testosterone deficiency contribute to this pathological pattern. The majority of patients with KS is diagnosed during adulthood, but symptoms can already become obvious during infancy, childhood or adolescence. The paediatric and juvenile patients with KS require specific attention regarding their development and fertility. Conclusion: These guidelines provide recommendations and suggestions to care for patients with KS in various developmental stages ranging from childhood and adolescence to adulthood. This advice is based on recent research data and respective evaluations as well as validations performed by a group of experts.

European academy of andrology guidelines on Klinefelter Syndrome. Endorsing organization: European Society of Endocrinology / Zitzmann, M.; Aksglaede, L.; Corona, G.; Isidori, A. M.; Juul, A.; T'Sjoen, G.; Kliesch, S.; D'Hauwers, K.; Toppari, J.; Slowikowska-Hilczer, J.; Tuttelmann, F.; Ferlin, A.. - In: ANDROLOGY. - ISSN 2047-2919. - 9:1(2021), pp. 145-167. [10.1111/andr.12909]

European academy of andrology guidelines on Klinefelter Syndrome. Endorsing organization: European Society of Endocrinology

Isidori A. M.;
2021

Abstract

Background: Knowledge about Klinefelter syndrome (KS) has increased substantially since its first description almost 80 years ago. A variety of treatment options concerning the spectrum of symptoms associated with KS exists, also regarding aspects beyond testicular dysfunction. Nevertheless, the diagnostic rate is still low in relation to prevalence and no international guidelines are available for KS. Objective: To create the first European Academy of Andrology (EAA) guidelines on KS. Methods: An expert group of academicians appointed by the EAA generated a consensus guideline according to the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) system. Results: Clinical features are highly variable among patients with KS, although common characteristics are severely attenuated spermatogenesis and Leydig cell impairment, resulting in azoospermia and hypergonadotropic hypogonadism. In addition, various manifestations of neurocognitive and psychosocial phenotypes have been described as well as an increased prevalence of adverse cardiovascular, metabolic and bone-related conditions which might explain the increased morbidity/mortality in KS. Moreover, compared to the general male population, a higher prevalence of dental, coagulation and autoimmune disorders is likely to exist in patients with KS. Both genetic and epigenetic effects due to the supernumerary X chromosome as well as testosterone deficiency contribute to this pathological pattern. The majority of patients with KS is diagnosed during adulthood, but symptoms can already become obvious during infancy, childhood or adolescence. The paediatric and juvenile patients with KS require specific attention regarding their development and fertility. Conclusion: These guidelines provide recommendations and suggestions to care for patients with KS in various developmental stages ranging from childhood and adolescence to adulthood. This advice is based on recent research data and respective evaluations as well as validations performed by a group of experts.
2021
Klinefelter syndrome; guidelines; hypergonadotropic hypogonadism; azoospermia
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
European academy of andrology guidelines on Klinefelter Syndrome. Endorsing organization: European Society of Endocrinology / Zitzmann, M.; Aksglaede, L.; Corona, G.; Isidori, A. M.; Juul, A.; T'Sjoen, G.; Kliesch, S.; D'Hauwers, K.; Toppari, J.; Slowikowska-Hilczer, J.; Tuttelmann, F.; Ferlin, A.. - In: ANDROLOGY. - ISSN 2047-2919. - 9:1(2021), pp. 145-167. [10.1111/andr.12909]
File allegati a questo prodotto
File Dimensione Formato  
Zitzmann_European-academy_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.67 MB
Formato Adobe PDF
1.67 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1557263
Citazioni
  • ???jsp.display-item.citation.pmc??? 42
  • Scopus 70
  • ???jsp.display-item.citation.isi??? 67
social impact